Sutro Biopharma Inc at JMP Securities Life Sciences Conference Transcript
Excellent. So good afternoon, everyone. Welcome to the JMP Securities Life Science Conference. It's my pleasure to introduce Sutro Biopharma. One of the I'd say pillars in the antibody -- in the ADC space. And you guys have heard obviously quite a bit of the news that's been going on. ADCs quite in vogue with the latest acquisitions in Pfizer and Seagen. Welcome, guys.
Presenting for the company is Bill and their new Chief Medical Officer.
Pleasure to be here.
Questions & Answers
Good to have you guys. So I never know who's in the audience and I know even last as to who's listening to replace. And so if you could, maybe in three to five minutes, just give us an overview of Sutro.
Sure. Sutro Biopharma is a publicly traded clinical stage oncology development company. We decided in 2010 to focus our research, which uses a novel, as you know,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
